HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The physiology and pathophysiology of inhibin, activin and follistatin in female reproduction.

Abstract
In the last 2 years, major advances have been made in the understanding of inhibin physiology. Discovery of an inhibin receptor and binding protein has expanded our knowledge of the mechanism whereby inhibin antagonizes activin action. Controlled experimental studies have clarified the regulation and physiology of inhibin A and inhibin B, providing evidence for their use as markers of ovarian function. Clinical studies continue to uphold the use of inhibin as a marker for ovarian cancer, but have not generally supported its use over standard prognostic markers in assisted reproductive technologies. Finally, ongoing work suggests alterations in inhibin and follistatin that may be linked to the pathophysiology of polycystic ovary syndrome. Thus, the mechanism of inhibin action and its role in normal and abnormal ovarian function continues to emerge.
AuthorsCorrine K Welt
JournalCurrent opinion in obstetrics & gynecology (Curr Opin Obstet Gynecol) Vol. 14 Issue 3 Pg. 317-23 (Jun 2002) ISSN: 1040-872X [Print] England
PMID12032389 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S., Review)
Chemical References
  • Follistatin
  • Activins
  • Inhibins
Topics
  • Activins (biosynthesis)
  • Female
  • Fertility (physiology)
  • Follistatin
  • Humans
  • Infertility, Female (physiopathology)
  • Inhibins (antagonists & inhibitors, biosynthesis)
  • Polycystic Ovary Syndrome (physiopathology)
  • Pregnancy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: